Summary. Fatty acids in cardiac muscle compete with glucose for oxidation, thereby inhibiting glucose utilisation. It is not clear whether a similar mechanism is important in resting skeletal muscle. We used the hyperinsulinaemic euglycaemic clamp technique in conscious rats fasted for 20 h to examine the effects of increased plasma non-esterifled fatty acid levels (-1 mmol/1) on glucose metabolism. Insulin was infused at 75mU/h (plasma insulin, 2.27 + 0.21 gg/1) or 300 mU/h (16.41 + 0.47 gg/1). An increase in non-esterified fatty acid levels decreased clamp glucose requirement and 3-~H-glucose turnover by 35% (p < 0.001) when the higher insulin dose was used but there was no change at the lower dose. At both insulin infusion rates, clamp blood lactate and pyruvate responses suggested inhibition of muscle glycolysis by elevated plasma non-esterified fatty acid concentrations. Quadriceps muscle glycogen deposition during the clamps was enhanced by increased non-esterified fatty acid availability at the lower insulin dose (p < 0.001) but not at the higher insulin concentration. Activation of pyruvate dehyrogenase during the clamps was partially inhibited by increased plasma non-esterified fatty acid in the heart, adipose tissue and quadriceps muscle. This was evident at both insulin levels in heart but only at the higher insulin concentration in muscle (p < 0.002). The findings are consistent with an inhibition of glycolysis in skeletal muscle of mixed fibre type as a result of increased fatty acid availability. At low rates of glucose flux glycogen synthesis may compensate for decreased glycolysis so that glucose turnover is not decreased. The role of pyruvate dehydrogenase in the "glucose-fatty acid cycle" in muscle may depend on the prevailing plasma insulin concentration and the degree of activation of this enzyme.Key words: Glucose-fatty acid cycle, non-esterified fatty acids, rat, glucose clamp, glycogen, glycogen synthase, pyruvate dehydrogenase, intermediary metabolites, glucose turnover.Inhibition of glucose uptake and oxidation in rat diaphragm and cardiac muscle by increased fatty acid oxidation was first demonstrated by Randle and colleagues [1]. They coined the term "glucose-fatty acid cycle" and suggested that increased availability of non-esterified fatty acids (NEFA) in obesity and diabetes may play an important role in the glucose intolerance and tissue insensitivity to insulin [2].Glucose tolerance was impaired when plasma NEFA concentrations were raised in normal man, by infusion of lipids [3,4] or administration of heparin with a fat meal [5]. As liver and skeletal muscle are quantitatively the most important tissues for disposal of an oral glucose load [6,7], it is necessary to postulate that increased fatty acid availability impairs glucose uptake by these tissues. Decreased insulin-stimulated muscle glucose uptake and impaired suppression of hepatic glucose production by insulin in rats fed a high fat diet for several weeks would support this [8,9]. However, the effects of an acute increase ...